title: Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.
abstract: Transcatheter (or percutaneous) renal denervation is a novel technique developed for the treatment of resistant hypertension. So far, only one randomised controlled trial has been published, which has shown a reduction of office blood pressure. The Swiss Society of Hypertension, the Swiss Society of Cardiology, The Swiss Society of Angiology and the Swiss Society of Interventional Radiology decided to establish recommendations to practicing physicians and specialists for good clinical practice. The eligibility of patients for transcatheter renal denervation needs (1.) confirmation of truly resistant hypertension, (2.) exclusion of secondary forms of hypertension, (3.) a multidisciplinary decision confirming the eligibility, (4.) facilities that guarantee procedural safety and (5.) a long-term follow-up of the patients, if possible in cooperation with a hypertension specialist. These steps are essential until long-term data on safety and efficacy are available.
authors.affiliation: Lausanne University Hospital, SWITZERLAND; gregoire.wuerzner@chuv.ch.
authors.forename: Gregoire
authors.initials: G
authors.lastname: Wuerzner
authors.forename: Olivier
authors.initials: O
authors.lastname: Muller
authors.forename: Paul
authors.initials: P
authors.lastname: Erne
authors.forename: Stéphane
authors.initials: S
authors.lastname: Cook
authors.forename: Isabella
authors.initials: I
authors.lastname: Sudano
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Lüscher
authors.forename: Georg
authors.initials: G
authors.lastname: Noll
authors.forename: Urs
authors.initials: U
authors.lastname: Kaufmann
authors.forename: Hans
authors.initials: H
authors.lastname: Rickli
authors.forename: Bernard
authors.initials: B
authors.lastname: Waeber
authors.forename: Christophe
authors.initials: C
authors.lastname: Kaiser
authors.forename: Christian
authors.initials: C
authors.lastname: Sticherling
authors.forename: Antoinette
authors.initials: A
authors.lastname: Pechère-Bertschi
authors.forename: Iris
authors.initials: I
authors.lastname: Baumgartner
authors.forename: Augustinus L
authors.initials: AL
authors.lastname: Jacob
authors.forename: Michel
authors.initials: M
authors.lastname: Burnier
authors.forename: Salah D
authors.initials: SD
authors.lastname: Qanadli
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D062186:Arterial Pressure; D032921:Consensus; D004351:Drug Resistance; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000601:surgery*; D007668:Kidney / Q000294:innervation*; D018579:Patient Selection; D013557:Switzerland; D013562:Sympathectomy / Q000009:adverse effects / Q000379:methods
chemical_list: D000959:Antihypertensive Agents